REGENERON

regeneron-logo

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcuta... neous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.
#People #Financial #Event #Website #More

REGENERON

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
1988-01-01

Address:
Tarrytown, New York, United States

Country:
United States

Website Url:
http://www.regeneron.com

Total Employee:
5001+

Status:
Active

Contact:
+118557343648

Total Funding:
8.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Domain Not Resolving



Current Advisors List

yitzhak-peterburg_image

Yitzhak Peterburg Chairman of the Board of Directors @ Regeneron
Board_member

marc-lavigne_image

Marc Lavigne Member of the Board of Directors @ Regeneron
Board_member

james-donohue_image

James Donohue Clinical Operations Innovation Lead @ Regeneron
Board_member
2020-02-01

Current Employees Featured

david-weinreich_image

David Weinreich
David Weinreich Executive Vice President, Head, Global Clinical Development @ Regeneron
Executive Vice President, Head, Global Clinical Development
2021-01-01

nanita-cranford_image

Nanita Cranford
Nanita Cranford Executive Director, Head of Global Regulatory Operations @ Regeneron
Executive Director, Head of Global Regulatory Operations
2020-02-01

aris-baras_image

Aris Baras
Aris Baras Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center @ Regeneron
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
2019-01-01

gregory-geba_image

Gregory Geba
Gregory Geba Senior Vice President, Global Development Scientific Council @ Regeneron
Senior Vice President, Global Development Scientific Council
2013-01-01

michael-selzer_image

Michael Selzer
Michael Selzer Manager, Combination Products Engineering @ Regeneron
Manager, Combination Products Engineering
2016-06-01

nouhad-husseini_image

Nouhad Husseini
Nouhad Husseini Business Development @ Regeneron
Business Development
2011-08-01

neil-stahl_image

Neil Stahl
Neil Stahl SVP Research and Development Sciences @ Regeneron
SVP Research and Development Sciences
1991-01-01

ned-braunstein_image

Ned Braunstein
Ned Braunstein Senior Vice President, Regulatory Affairs @ Regeneron
Senior Vice President, Regulatory Affairs
2015-01-01

katia-karalis_image

Katia Karalis
Katia Karalis Executive Director, RGC, Regeneron Pharmaceuticals @ Regeneron
Executive Director, RGC, Regeneron Pharmaceuticals
2020-06-01

sally-paull_image

Sally Paull
Sally Paull Senior Vice President, CHRO @ Regeneron
Senior Vice President, CHRO
2016-04-01

Founder


eric-shooter_image

Eric Shooter

george-d-yancopoulos_image

George D. Yancopoulos

leonard-s-schleifer_image

Leonard S. Schleifer

Stock Details


Company's stock symbol is NASDAQ:REGN

Acquisitions List

Date Company Article Price
2022-04-19 Checkmate Pharmaceuticals Checkmate Pharmaceuticals acquired by Regeneron 250 M USD

Investors List

u-s-department-of-health-human-services-ahrq_image

U.S. Department of Health & Human Services

U.S. Department of Health & Human Services investment in Post-IPO Equity - Regeneron

Investments List

Date Company Article Money raised
2022-05-17 Vyriad Regeneron investment in Series B - Vyriad 29.5 M USD
2020-06-09 DNAnexus Regeneron investment in Series G - DNAnexus 100 M USD
2019-09-02 Adicet Bio Regeneron investment in Series B - Adicet Bio 80 M USD
2019-04-08 Alnylam Pharmaceuticals Regeneron investment in Post-IPO Equity - Alnylam Pharmaceuticals 800 M USD
2018-06-19 Decibel Therapeutics Regeneron investment in Series C - Decibel Therapeutics 55 M USD

Newest Events participated

2022-master-data-marathon-40_event_image Participated in 2022 Master Data Marathon 4.0 on 2022-04-06 as speaker

2017-annual-ostem-conference_event_image Participated in 2017 Annual oSTEM Conference on 2017-11-16 as sponsor

Official Site Inspections

http://www.regeneron.com Semrush global rank: 341.1 K Semrush visits lastest month: 176.15 K

  • Host name: 192.103.124.65
  • IP address: 192.103.124.65
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Regeneron" on Search Engine